Monday, November 30, 2009

Bapineuzumab, ICARA Study: Experimental Alzheimers drug offers new hope for patients

The big point we have is I'm still here. I'm still me. -- Alan Romatowski
On this day, he's not forgetting difference in midsentence. He doesn't feel confused about anything. Alan insightfully answers questions acted by his neurologist, Dr. Oscar Lopez, about what might be function to a Alzheimer's-related amyloid board infiltrating his brain.

To review some-more about Alan Romatowski -- go here.
Subscribe to The Alzheimer's Reading Room--via Email
Researchers wish to see if a drug can delayed a course of Alzheimers mildew by restraint a amyloid precursor protein, which causes a brain cells to stop working. Amyloid beta peptide is a first protein found in amyloid plaques in a brains of patients with Alzheimers disease. It is expected that by restraint a formation of this peptide, a rate of mildew course can be slowed.
Our goal is to try if this investigational drug can help control a course of Alzheimers, said Franklin Watkins, M.D., a principal questioner for a investigate as well as medical executive for a Acute Care for a Elderly Unit at a Medical Center. Most stream therapies for Alzheimers treat a symptoms associated with it as well as not a mildew itself. It is critical for patients as well as families influenced by Alzheimers to cruise participating in clinical studies. They have been a most appropriate possibility we have for fighting this disease.

This clinical hearing has a own website - Investigational Clinical Amyloid Research in Alzheimer's (ICARA).

To view a ICARA investigate site -- go here.

The ICARA website has a separate page where we can request as well as determine if we have been authorised to be interviewed for a clinical trial.
  • If we wish to determine if there is a investigate place nearby we -- go here as well as come in your zip code. There have been 193 locations in North American alone so this is a widely available clinical trial.
  • If we would like to see if we or a loved a single is authorised -- go here as well as fill out a form upon a Internet. This is a first necessary step if we wish to experience in a clinical trial.

If we have been incompetent to make use of a Internet, or if we have been severely interested in a clinical hearing my idea would be to call this telephone number-- 877-797-8839 -- to start a process.

Go here to see all a persisting Bapineuzumab clinical trials.



Popular articles upon a Alzheimer's Reading Room

  • Worried About Alzheimer's Disease
  • Dementia as well as a Eight Types of Dementia
  • H1N1 Flu Virus Everything You Need to Know
  • Does a Combination of Aricept as well as Namenda Help Slow a Rate of Decline in Alzheimer's Patients
  • Test Your Memory (TYM) for Alzheimer's or Dementia in Five Minutes
  • Dimebon Connection Study
  • The Metamorphosis of This Alzheimer's Caregiver (Part One)
  • The Mini-Cog Test for Alzheimer's as well as Dementia
  • Worried about Alzheimer's? Five Ways to Protect Yourself
  • Is it Really Alzheimer's or Something Else?
  • Alzheimer's Wandering Why it Happens as well as What to Do
  • 50 Good Reasons to Subscribe to a Alzheimer's Reading Room Now
  • World Health Care Spending as well as Performance Ranking by Country (Table)
  • Urinary Incontinence -- How We Beat Alzheimer's Incontinence
  • Are Alzheimer's Caregivers a Forgotten?
  • A Simple Three Minute Test Can Detect a Earliest Stage of Alzheimer's Disease
  • Wii a Useful Tool for Alzheimer's Caregivers
  • 2009 Alzheimer's Disease Facts as well as Figures

Bob DeMarco is a editor of a Alzheimer's Reading Room as well as an Alzheimer's caregiver. The Alzheimer's Reading Room is a series a single website upon a Internet for news, advice, as well as discernment into Alzheimer's disease. Bob has written some-more than 950 articles with some-more than 8,000 links upon a Internet. Bob resides in Delray Beach, FL.

Original content Bob DeMarco, Alzheimer's Reading Room

No comments:

Post a Comment